Bio-Path Holdings, Inc.
BPTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133818
No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Bio-Path Holdings, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- 0 vs. Q3 2021
- Shares held
- 450.2K
- +16.0K (+3.7%) vs. Q3 2021
- Total value
- $1.70M
- −$530.0K (−23.8%) vs. Q3 2021
- New holders
- 3
- 2 more added
- Sold out
- 3
- 3 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BPTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $5.29K |
| Q4 2024 | 22 | $370.1K |
| Q3 2024 | 14 | $53.5K |
| Q2 2024 | 13 | $285.1K |
| Q1 2024 | 10 | $78.6K |
| Q4 2023 | 19 | $276.5K |
| Q3 2023 | 23 | $256.6K |
| Q2 2023 | 18 | $812.0K |
| Q1 2023 | 21 | $793.1K |
| Q4 2022 | 21 | $976.3K |
| Q3 2022 | 19 | $1.47M |
| Q2 2022 | 17 | $1.59M |
| Q1 2022 | 17 | $1.51M |
| Q4 2021 | 17 | $1.70M |
| Q3 2021 | 17 | $2.23M |
| Q2 2021 | 17 | $2.94M |
| Q1 2021 | 19 | $3.31M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Bio-Path Holdings, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 216,062 | $815.0K | 0.00% | −2,930−1.3% | Reduced |
| BlackRock Inc. | 66,011 | $249.0K | 0.00% | −1,729−2.6% | Reduced |
| Geode Capital Management, LLC | 65,783 | $248.0K | 0.00% | 00.0% | Unchanged |
| Bailard, Inc. | 33,521 | $126.0K | 0.00% | +33,521 | New |
| Morgan Stanley | 19,424 | $73.0K | 0.00% | −1,706−8.1% | Reduced |
| Northern Trust Corp | 18,099 | $68.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 15,375 | $58.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 12,133 | $46.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,248 | $12.0K | 0.00% | +2,442+303.0% | Added |
| Captrust Financial Advisors | 250 | $1.00K | 0.00% | +250 | New |
| Bank of America Corp | 22 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 44 | $0 | 0.00% | +1+2.3% | Added |
| AdvisorNet Financial, Inc | 40 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 14 | $0 | 0.00% | 00.0% | Unchanged |
| Crewe Advisors LLC | 70 | $0 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 69 | $0 | 0.00% | 00.0% | Unchanged |
| Aquire Wealth Advisors, LLC | 3 | $0 | 0.00% | +3 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −12,404−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,405−100.0% | Sold out |
| Ironwood Financial, llc | 0 | $0 | 0.00% | −82−100.0% | Sold out |